Clinical Trials

Page
12345›»

Cylene Pharmaceuticals, Inc. Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2

Cylene Pharmaceuticals announced today that it has initiated a Phase I clinical...

Tuesday, January 06, 2009 Source: PRNewswire

Discovery Labs' Surfaxin(r) Phase 2 BPD Clinical Trial Results Published in Pediatrics

Discovery Laboratories, Inc. (Nasdaq:DSCO) announces the publication of results...

Tuesday, January 06, 2009 Source: GLOBE NEWSWIRE

Immutep S.A. Announces Positive Interim Results in Phase I/II Chemoimmunotherapy Trial in Breast Cancer

Orsay, France, January 5th, 2009, Immutep S.A. announced today interim results...

Tuesday, January 06, 2009 Source: BioSpace.com

DOR BioPharma, Inc. (DORB) Receives SPA Clearance From the FDA to Begin Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD

DOR BioPharma, Inc. (DOR or the Company) (OTCBB: DORB)...

Tuesday, January 06, 2009 Source: Marketwire

Halozyme Therapeutics, Inc. (HALO) Phase III Trial Begins for GAMMAGARD LIQUID Plus RHuPH20 in Primary Immunodeficiency Patients

Baxter International Inc. and Halozyme Therapeutics, Inc. today announced the...

Tuesday, January 06, 2009 Source: PRNewswire

YM BioSciences (YM.TO)' NIMOTUZUMAB Selected for Multinational Phase 3 Trial

YM BioSciences Inc. , an oncology company that identifies, develops and commercializes...

Tuesday, January 06, 2009 Source: PRNewswire

Phase III Trial Begins For GAMMAGARD LIQUID Plus RHuPH20 In Primary Immunodeficiency Patients

Baxter International Inc. and Halozyme Therapeutics, Inc. today announced the...

Monday, January 05, 2009 Source: Halozyme Therapeutics, Inc.

Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-In Class Inhibitor Of CK2

Cylene Pharmaceuticals announced today that it has initiated a Phase I clinical...

Monday, January 05, 2009 Source: Cylene Pharmaceuticals

Savient Pharmaceuticals, Inc. (SVNT) Says FDA Gives Fast Review to Gout Drug

Savient Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration...

Tuesday, December 30, 2008 Source: PRNewswire

Novartis Strengthens Vaccine Pipeline with Agreement for Novel CMV Vaccines Candidate

Novartis has strengthened its vaccines pipeline through an exclusive agreement...

Tuesday, December 30, 2008 Source: PharmaLive
Page
12345›»

News Search

Search News By Keywords

News Sections

New Technologies

FluoView® FV10i
from Olympus
3D Track Objects
from Molecular Devices, now a part...
More New Technologies
advertisement
Advertisement (image not found)

Email Newsletter Sign-Up

Stay updated on the latest technologies and news with Biocompare's newsletters
(See samples here)









 Select All

Privacy Policy | Manage Subscriptions

Loading

Loading